Clinical Trial Update: TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating drug-drug interactions between etravirine or rilpivirine and telaprevir; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Edurant (rilpivirine)
• Incivek (telaprevir)
• Intelence (Etravirine)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C, HIV | Phase 1 | Status: COMPLETED